Wei Lu
5PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.Ningning Zhang, Tian Liu, Ming Luo
|May 07, 2024
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma.Jiaxin Han, Wentao Kuai, Liu Yang
|Feb 06, 2023
HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression.Yufei Wang, Man Zhao, Lina Zhao
|Dec 31, 2020
Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.Jia Yu Lv, Ning Ning Zhang, Ya Wei Du
|Nov 22, 2019
Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria.Ningning Zhang, Wentao Jiang, Yamin Zhang
Pageof 1
